Help us maintain the quality of our job listings. If you find any issues with this job post, please let us know.
Select the reason you're reporting this job:
To those who say “impossible, impractical, unrealistic,” we say: “CHALLENGE ACCEPTED.”
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring RNAi-based medicines to market.
We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases.
Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today’s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate.
Alnylam is turning scientific possibility into reality - in 2018, the FDA and EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. We now have four additional medicines on the market. Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development.
We are a global and diverse company of 1,900+ people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we've been named a Science Magazine Top Employer 3 years in a row ('19-'21), a Boston Globe Top Place to Work 8x in a row ('15-'21) and Fast Company's #1 Best Workplace for Innovators ('22
We are based in Cambridge, U.S., with offices throughout Europe, Asia, and South America.
We invite you to connect with us by following us on LinkedIn, Facebook (@AlnylamPharma) Twitter (@Alnylam), Instagram (@AlnylamPharma) and YouTube.
See our community guidelines: https://bit.ly/2FcRhJy.
We are looking for an experienced and talented Business Account Executive (BAE) to commercially represent GIVLAARI® and OXLUMO® in the United States and have a significant impact on the lives of AHP patients. AHP’s represent a sub-group of Porphyrias, characterized by the occurrence of neuro-visceral attacks with or without cutaneous manifestations. AHP’s include four disorders: acute intermittent porphyria (the most common), variegate porphyria, hereditary coproporphyria, and a genetic deficit of delta-aminolaevulinic acid dehydratase. PH1 is a rare, life-threatening disease that can cause serious damage to kidneys and progressively to other organs. PH1 is a little-known condition, and patients often spend years undiagnosed and misdiagnosed.
The BAE will be principally responsible for driving physician and patient identification, disease awareness, overall market development, and brand awareness within their ascribed territory. The BAE will be responsible for achieving territory targets and other business objectives through account and customer strategies, while also partnering & collaborating very closely with internal and external stakeholders to effectively manage all aspects of the regional business. The achievement of targets will be based in Alnylam’s values: our commitment to people, sense of urgency, passion for excellence, innovation & discovery, and open culture as well as our unwavering commitment to integrity.
The BAE will report to the Regional Business Director (RBD) for their respective region. Territory includes San Diego, Orange County, CA and Hawaii.
Key Responsibilities
Drive patient identification through appropriate HCP driven strategies including market development, increase brand awareness through building and executing a territory strategy/account plan; continuously assess opportunities within markets and accounts to launch successfully.
Effectively prioritize and manage time, activities, and resources in order to optimize access to academic and community HCPs.
Build and maintain relationships with HCPs and office staff by maximizing their time through planning, leveraging insights, and conducting post-call analysis refining tactics based on opportunities.
Proactively build effective working relationships with internal/external stakeholders; drive agreement/decisions from multiple stakeholders; demonstrated high level of emotional intelligence adapting communication based on different stakeholders.
Collaborate with stakeholders across all commercial departments including; patient services, field reimbursement, and others to ensure access at site of care and that logistics are in place to administer medications.
Collaborate with key accounts and physicians to build individual account plans to drive patient identification through market development and physician education; achieve sales goals, and maintain relationships in order to maximize sales results.
Execute speaker programs, local sponsorships, displays and exhibits, both in and out of office across multiple account types: academic institutions, physician offices, infusion centers, and alternate site locations.
Routinely report territory-level market dynamics and trends, including prescriber opinion and competitive activity to RBD as required.
Qualifications
Bachelor’s degree required
7+ years of demonstrated success in biotech, specialty pharmaceuticals, or medical devices.
Recent rare/ultra-rare disease experience within the past 5 years.
Experience, success and relationships in Gastroenterology, Hepatology, Neurology, Hematology/Oncology, pediatric and adult Nephrology and/or Urology are preferred but not required.
Buy & Bill understanding and experience working with HUB patient services preferred but not required.
Thorough understanding of site of care identification, development and education.
Strong examples of applied entrepreneurial mindset, business analytics and data analysis required.
Experience supporting biologic therapy administered by designated HCPs preferred.
Experience driving, leading and delivering upon territory-level cross functional business planning.
Must be familiar with relevant legal and regulatory environment in biotech/pharmaceutical industry.
Strong communication and listening skills.
Effective at managing complex individualized cases in a compliant manner.
Overnight travel required including travel to Boston, congresses and large geographical territories
Candidates must have a valid driver's license.
Must live in the assigned territory.
Required profile
Experience
Industry :
Biotech: Biology + Technology
Spoken language(s):
English
Check out the description to know which languages are mandatory.